BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Everest Medicines Gets NMPA Approval for Nefecon® in China for IgA Nephropathy

--Nefecon® is the first approved medicine with an IgAN indication in China-- --The approval marks a new era of IgAN treatment for Chinese patient...

November 27, 2023 | News

DxVx Plans License-In of OVM-200, Launches Clinical Trials in Asia

Final stage in licensing OVM-200 from Oxford Vacmedix in the UK- DxVx plans to proceed its own clinical trials in Asia, including Korea and Chi...

November 27, 2023 | News

China Faces Surge in 'Undiagnosed Pneumonia' Cases Among Children

The outbreak initially surfaced in northern China, prompting the World Health Organization (WHO) to issue an "official request" to ...

November 27, 2023 | News

Simcere and Connect ink exclusive deal for autoimmune drug Rademikibart.

Pursuant to the Agreement, Simcere obtains the exclusive rights in the development, manufacturing, and commercialization of Rademikibart for all indication...

November 24, 2023 | News

BeiGene and Ensem Therapeutics Partner to Advance CDK2 Inhibitor

“We are committed to developing novel molecules with the potential to transform the therapeutic landscape for cancer patients, and this partnership f...

November 23, 2023 | News

WuXi Biologics Achieves Breakthrough Productivity of ~6 g/L/day in Integrated Continuous Process at Pilot Scale

By leveraging WuXiUPTM, WuXi Biologics has completed its first end-to-end continuous drug substance (DS) manufacturing from perfused cell culture...

November 23, 2023 | News

Innovent and AnHeart's Taletrectinib NDA Accepted by China's NMPA

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality me...

November 23, 2023 | News

XtalPi and EDDC Collaborate on Biomedical Innovation with Robotics and Language Models

Building upon an ongoing collaboration that was initiated in December 2022 to utilize artificial intelligence (AI) and automation to develop targ...

November 22, 2023 | News

IASO Bio Sets Up Global CAR-T Center in China for Global MM Patients

On June 30, 2023, the China National Medical Products Administration (NMPA) approved the marketing of Equecabtagene Autoleucel Injection (brand name: FUCAS...

November 22, 2023 | News

Porton Advanced and Ascle Therapeutics Form Strategic Partnership for NK Cell Applications in Cancer Prevention, Beauty, and Anti-aging

Porton Advanced is committed to providing end-to-end gene and cell therapy CDMO services, covering fields such as plasmids, cell therapy, gene therapy, and...

November 21, 2023 | News

WuXi XDC Successfully Listed on the Main Board of Hong Kong Stock Exchange

WuXi XDC issued a total of 178,446,000 shares under the global offering at an offer price of HK$20.60 per share (being the high-end of the indica...

November 20, 2023 | News

Sanyou Unveils "STAL Innovative Biologics Drug Discovery Platform" – Transforming Drug Discovery Landscape

This cutting-edge platform surpasses conventional methods, enabling the screening of thousands of innovative lead molecules against common targets. Sanyou ...

November 20, 2023 | News

AmoyDx and CST Expand Existing Partnership for the Development of Companion Diagnostics (CDx) to Support Precision Oncology

As the use of precision oncology therapeutics continues to advance in China, the partnership will provide AmoyDx with access to additional, highly validate...

November 15, 2023 | News

BioDuro-Sundia Elevates Innovation with Advanced Radioisotope Lab Upgrades

Especially, it has unsurpassed specificity and sensitivity in the detection of membrane receptors such as GPCR receptor-ligand binding affinity test and ex...

November 15, 2023 | News

Stay Connected